PEI – starch nanoparticles for cancer gene therapy

Download
2013
Kandemir, Berke Bilgenur
Cancer is the most serious disease of in this century and death rates due cancer are increasing rapidly. Since the conventional cancer treatment techniques like chemotherapy, radiation therapy and surgical operations are not sufficiently efficient and they even are harmful for healthy tissues, there is an urgent need for effective treatment techniques with minimal or no side effects. Controlled drug delivery systems are offered as an alternative approach to cancer therapy that helps prevent excessive drug use and may even target the drug to the disease site. It was shown that one of the most efficient therapeutic agents is the use of gene therapy involving siRNA. Cationic nanoparticles are known to be efficient tools in siRNA delivery specificially into the targeted tumor cells. This study aims to develop an autophagic siRNA delivery system to cancer cells using positively charged nanospheres of polyethylenimine(PEI) – starch which possess the required positive charge by employing PEI molecules while lowering the cytotoxic effect of PEI through complexation with starch. PEI-starch nanospheres were prepared by water-in-oil microemulsion method. The size and zeta potential of the PEI-starch nanospheres were characterized by measuring the zeta potential and the particle size, and studying the topography with SEM. Mean diameter of unloaded particles was 60.3 nm and upon loading with siRNA this increased to 84.6 nm. SEM micrographs revealed that the nanospheres were very uniform (NIH Image J was used to measure the diameter using the micrographs) and had smooth surfaces. However, batch-to-batch size variation of the particles was observed. vi Zeta potential of PEI-starch nanoparticles increased when the PEI /starch ratios were increased, with the highest surface charge of 8.7 mV (PEI:Starch, 9:1 (w/w)). The encapsulation efficiency of the nanospheres was 1.5 % and this could be increased by optimizing pH conditions of water phase, and also the crosslinking and washing conditions. The nanospheres released 50 % of their siRNA content in the first 3 days and all of the content in a week. Confocal laser scanning microscopy (CLSM) micrographs show the nanoparticles affiliated with MCF 7 cells and additional staining of the nucleus is able to show their location more adequately. Western blot of breast cancer cells treated with EF2K siRNA loaded nanoparticles showed that the EF2K production which leads to proliferation of cancer cells was silenced after the treatment with the siRNA loaded nanoparticles.

Suggestions

Synthesis of poly (dl-lactic-co-glycolic acid) coated magnetic nanoparticles for anti-cancer drug delivery
Tansık, Gülistan; Gündüz, Ufuk; Department of Biology (2012)
One of the main problems of current cancer chemotherapy is the lack of selectivity of anti-cancer drugs to tumor cells which leads to systemic toxicity and adverse side effects. In order to overcome these limitations, researches on controlled drug delivery systems have gained much attention. Nanoscale based drug delivery systems provide tumor targeting. Among many types of nanocarriers, superparamagnetic nanoparticles with their biocompatible polymer coatings can be targeted to an intented site by an extern...
Investigaton of chemopreventive properties of Urtica Dioica L., in MCF-7 and MDA231 breast cancer cell lines
Güler, Elif; İşcan, Mesude; Department of Biology (2011)
Cancer is a major health problem in developing world with mostly unsufficient treatment. Cancer prevention through dietary modification appears to be a practical and cost effective possibility. The aim of present study is to investigate the chemical components of “Urtica diocia,L (U. diocia) grown in Turkey” and the possible protective potential of its aqueous extract against breast cancer cell lines. U. diocia was extracted by maceration method which was performed for 6,12, 24, and 36 hours, at 50°C, 37°C,...
Tailoring magnetic PLGA nanoparticles suitable for doxorubicin delivery
Tansik, Gulistan; YAKAR, ARZU; Gündüz, Ufuk (2013-12-07)
One of the main problems of current cancer chemotherapy is the lack of selectivity of anti-cancer drugs to tumor cells, which leads to systemic toxicity and adverse side effects. In order to overcome these limitations, researches on controlled drug delivery systems have gained much attention. Nanoscale-based drug delivery systems provide tumor targeting. Among many types of nanocarriers, superparamagnetic nanoparticles with their biocompatible polymer coatings can be targeted to an intented site by an exter...
The Mechanism of anti tumorigenic effects of 15-lox-1 in colon cancer
Çimen, İsmail; Banerjee, Sreeparna; Department of Biology (2012)
Colorectal cancer is the 4th most widespread cause of cancer mortality. One of the pathways that are involved in the development of colorectal cancer is the arachidonic acid metabolizing lipoxygenase (LOX) pathway. Inflammatory molecules formed from this pathway exert profound effects that may exacerbate the development and progression of colon and other cancers. 15 lipoxygenase-1 (15-LOX-1) is a member of LOX protein family that metabolizes primarily linoleic acid to 13-(S)-HODE. Several lines of evidence ...
Structural mapping and network analysis of patient-specific mutations in glioblastoma
Kaya, Tuğba; Tunçbağ, Nurcan; Doğan, Tunca; Department of Bioinformatics (2018)
Cancer is one of the most common cause of death worldwide. It occurs as a result of a collection of somatic deviations from normal state. Therefore, many efforts have been invested to profile mutations in different types of tumors; such as, the Cancer Genome Atlas (TCGA) which deposits multiple omic data for more than 11,000 tumor samples. In this thesis, we present a pipeline which retrieves patient-specific mutation data in Glioblastoma from TCGA, maps these mutations on the protein structures in Protein ...
Citation Formats
B. B. Kandemir, “PEI – starch nanoparticles for cancer gene therapy,” M.S. - Master of Science, Middle East Technical University, 2013.